Literature DB >> 4348178

The effects of some phosphodiesterase inhibitors on the conductance of the perfused vascular beds of the chloralosed cat.

T C Hamilton.   

Abstract

1. The vasoactivity of a number of phosphodiesterase inhibitors in the auto-perfused splanchnic region and hindquarters of the cat have been investigated.2. Theophylline, dipyridamole and 4-(3,4-dimethoxybenzyl)-2-imidazolidinone (Ro 7-2956) and its analogues were more potent vasodilators in the splanchnic region than in the hindquarters, whereas papaverine was a potent vasodilator in both these vascular beds.3. The vasodilator response to the phosphodiesterase inhibitors in the splanchnic region and hindquarters was not susceptible to beta-adrenoceptor blockade.4. Infusion of dibutyryl cyclic AMP into the superior mesenteric artery increased vascular conductance of the splanchnic region. This effect was enhanced by Ro 20-1724 in doses below those in which this compound affected conductance.5. These results are consistent with the hypothesis that accumulation of cyclic AMP in vascular smooth muscle mediates the vasodilator response to phosphodiesterase inhibitors.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4348178      PMCID: PMC1666505          DOI: 10.1111/j.1476-5381.1972.tb08135.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  21 in total

1.  Inhibition of cyclic-3',5'-nucleotide-phosphodiesterase as a possible mode of action of papaverine and similarly acting drugs.

Authors:  W R Kukovetz; G Pöch
Journal:  Naunyn Schmiedebergs Arch Pharmakol       Date:  1970

2.  Investigation of the mechanism of action of the lipolytic agent 4-(3,4-dimethoxybenzyl)-2-imidazolidinone (Ro 7-2956).

Authors:  C Dalton; J B Quinn; C R Burghardt; H Sheppard
Journal:  J Pharmacol Exp Ther       Date:  1970-06       Impact factor: 4.030

3.  Cyclic phosphodiesterase activity and the action of papaverine.

Authors:  L Triner; Y Vulliemoz; I Schwartz; G G Nahas
Journal:  Biochem Biophys Res Commun       Date:  1970-07-13       Impact factor: 3.575

4.  Cyclic 3'5'-AMP, its dibutyryl derivative and theophylline effects on the rat portal vein in vitro.

Authors:  F Berti; C Sirtori; M M Usardi
Journal:  Arch Int Pharmacodyn Ther       Date:  1970-04

Review 5.  Sympathin E, sympathin I, and the intracellular level of cyclic AMP.

Authors:  G A Robison; E W Sutherland
Journal:  Circ Res       Date:  1970-07       Impact factor: 17.367

6.  Relaxation of the guinea-pig tracheal chain preparation by N6,2'-O-dibutyryl 3',5'-cyclic adenosine monophosphate.

Authors:  P F Moore; L C Iorio; J M McManus
Journal:  J Pharm Pharmacol       Date:  1968-05       Impact factor: 3.765

Review 7.  Vascular smooth muscle. I. Normal structure, pathology, biochemistry, and biophysics.

Authors:  A P Somlyo; A V Somlyo
Journal:  Pharmacol Rev       Date:  1968-12       Impact factor: 25.468

Review 8.  Control of resistance, exchange, and capacitance functions in the peripheral circulation.

Authors:  S Mellander; B Johansson
Journal:  Pharmacol Rev       Date:  1968-09       Impact factor: 25.468

9.  Effect of dipyridamole on vasodilator responses to ischemia, hypoxia, ATP, and AMP.

Authors:  H A Kontos; D Goldin; D W Richardson; J L Patterson
Journal:  Am J Physiol       Date:  1968-01

10.  The significance of adenosine cyclic 3',5'-monophosphate for the contraction of smooth muscle.

Authors:  H J Bartelstone; P A Nasmyth; J M Telford
Journal:  J Physiol       Date:  1967-01       Impact factor: 5.182

View more
  1 in total

1.  Effects of dipyridamole on neurogenic and non-neurogenic dilator responses of arterial smooth muscle.

Authors:  C Bell
Journal:  Br J Pharmacol       Date:  1974-09       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.